Evidence map›Paper›PMID 41415928›Full record

ArticleThe journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG2025

Retrospective Review of Prednisolone Use in Late Pre-term and Term Infants With Persistent Oxygen Requirements.

Chandler Batson, Jenda Arawiran, Sumesh Parat, Sherry Luedtke

Abstract read
In one paragraph

Article in The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chandler BatsonTexas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy (CB, SL).
Jenda ArawiranParkridge East Hospital, Chattanooga, TN (JA).
Sumesh ParatTexas Tech University Health Sciences Center School of Medicine (SP).
Sherry LuedtkeTexas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy (CB, SL).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe primary objective of this study was to evaluate the number of late pre-term and term neonates who were able to wean off oxygen after receiving short-course prednisolone therapy.

methodsA retrospective review of prednisolone treatment in oxygen-dependent infants was performed on infants admitted to the neonatal intensive care unit (NICU) at Northwest Texas Hospital, Amarillo, Texas, and received oral prednisolone therapy between January 1, 2021, through January 2023. Patients included were born ≥ 34 weeks gestation and received prednisolone therapy for oxygen weaning. Data collection comprised of maternal and infant medical conditions, medications, oxygen requirements, chest x-ray findings, and length of stay. Prednisolone dosing, duration, and reported adverse effects were collected. Descriptive statistics such as mean and median were used to describe patient characteristics and outcomes.

resultsThirteen of the 26 infants admitted met the inclusion criteria. Seven (53.8%) were successfully weaned to room air; of these, 5 were weaned to room air by the sixth dose of prednisolone. Neonates with meconium-stained amniotic fluid had an 75% success rate (3 out of 4), and those with suspected/diagnosed transient tachypnea of the newborn (TTN) had 57.1% success (4 out of 7 infants).

conclusionsPrednisolone therapy shows promising efficacy in weaning late pre-term and term infants off oxygen. Future randomized controlled trials are needed to determine the role and optimal prednisolone regimen.

Indexed as

infantneonateoxygen supplementationprednisoloneTTN

Identifiers

PMID41415928
PMCPMC12710493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.